Get started
Author

Bolivar Luis Diaz Jordan

Observed names: Bolivar Diaz Jordan, Bolivar L Diaz-Jordan, Bolívar L. Díaz-Jordán, Bolívar L. Díaz Jordán, Bolívar L Díaz-Jordán, Bolívar Luis Díaz Jordán, Bolívar Luis Díaz‐Jordán
ORCID: 0009-0006-7783-7951
Observed ORCID: 0009-0006-7783-7951
OpenAlex ID: A5065232824
Expert opinion paper on the treatment of hemophilia A with emicizumab
2023 · Francisco-José López-Jaime, Olga Benítez, et al. · Hematology · 24
Real-World Evidence on Joint Condition in Non-Severe Hemophilia A Patients: A Multicenter Study
2025 · Ana Marco-Rico, José Manuel Calvo-Villas, et al. · Journal of Blood Medicine · 2
PDF
PB3385 Management of Patients with Factor VII Deficiency in Surgery: A Single-center Experience
2026 · Bolivar Luis Diaz Jordan · Research and Practice in Thrombosis and Haemostasis
PDF
PB1624 Venous thromboembolic disease and chronic lymphocytic leukemia with treatment criteria: multicenter experience in Spanish centers
2026 · Bolivar Luis Diaz Jordan · Research and Practice in Thrombosis and Haemostasis
PB2173 Pediatric Cohort Treated With rIX-FP (Idelvion): Real-World Analysis of Efficacy, Safety, PK Improvement and Resource Utilization
2026 · Olga Benitez Hidalgo, Bolivar Luis Diaz Jordan · Research and Practice in Thrombosis and Haemostasis
Gastrointestinal toxicity in the treatment of hematological tumors. Influence on nutritional status
2026 · Teresa Alonso Domínguez, Miguel Civera Andrés, et al. · Endocrinología Diabetes y Nutrición (English ed )
Joint Damage Prediction in Non-Severe Hemophilia A with Artificial Intelligence
2026 · Ana Marco-Rico, José Manuel Calvo-Villas, et al. · Journal of Blood Medicine
PDF
Toxicidad digestiva en el tratamiento de los tumores hematológicos. Influencia en el estado nutricional
2026 · Teresa Alonso Domínguez, Miguel Civera Andrés, et al. · Endocrinología Diabetes y Nutrición
Using Artificial Intelligence to Predict Joint Damage in Non-Severe Hemophilia A
2025 · Ana Marco Rico, José Manuel Calvo Villas, et al. · SSRN Electronic Journal
Home Care in Oncohematological Patients Not Candidates for Intensive Chemotherapy: From Active Treatment to the End of Life. Ambispective Multicentric Study on Dual and Early Assessment of Palliative Care and Hematology in a Rural Environment
2024 · Bolivar Diaz Jordan, Marta Torcal Baz, et al. · Blood
PDF
Real‐world experience of rIX‐FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID ‐19 pandemic
2023 · Bolívar Luis Díaz‐Jordán, Tamara Cebanu, et al. · Clinical Case Reports
PDF
Descriptive and Epidemiological Study of Joint Damage in Non-Severe Hemophilia: Update of the Damage Study of the Mediterranean Group
2023 · Ana Marco Rico, Jose Manuel Calvo-Villas, et al. · Blood
PDF
Pb2677: Home Care in Oncohematological Patients Not Candidates for Intensive Chemotherapy: From the Active Treatment Until the End of Life. Pioneer Experience of a Rural Hematopalliative Unit.
2023 · Bolivar Luis Diaz Jordan, Marta Torcal Baz · HemaSphere
Pilot, Multicenter and Cross-Sectional Study of Joint Health in Patients with Non-Severe Hemophilia
2022 · Ihosvany Fernandez-Bello, Jose Manuel Calvo-Villas, et al. · Blood
Differences in Activated Partial Thromboplastin Time (APTT) measures depending on the device used in blood samples drawn (direct Vacutainer® versus Butterfly needle): A Randomized Comparative Study
2016 · Ana Belen Friginal, Ángel Arias, et al. · International journal of nursing
Works count: 15
Citation count: 26
H-index: 2
I10-index: 1
Year
Topic
Type